LabCorp Biorepository Receives Industry Accreditation from College of American Pathologists

BURLINGTON, N.C. --(BUSINESS WIRE)--Jan. 9, 2013-- Laboratory Corporation of America ® Holdings (LabCorp ® ) (NYSE: LH) today announced the recent accreditation of its Biorepository by the College of American Pathologists (CAP). CAP’s inaugural accreditation program was developed to establish

LabCorp is Scheduled to Present at the 31st Annual J.P. Morgan Healthcare Conference

BURLINGTON, N.C. --(BUSINESS WIRE)--Jan. 4, 2013-- Laboratory Corporation of America ® Holdings (LabCorp ® ) (NYSE: LH) today announced that David P. King , Chairman and Chief Executive Officer, is scheduled to speak at the 31 st Annual J.P. Morgan Healthcare Conference in San Francisco, CA.

Conversion Right Triggered for LabCorp’s Zero Coupon Convertible Subordinated Notes Due 2021

BURLINGTON, N.C. --(BUSINESS WIRE)--Jan. 2, 2013-- Laboratory Corporation of America ® Holdings (LabCorp ® ) (NYSE: LH) announced today that its Zero Coupon Convertible Subordinated Notes due 2021 (Zero Coupon Notes) may be converted as set forth below.

Laboratory Corporation of America® Holdings Announces 2012 Third Quarter Results

LabCorp Reports Q3 Diluted EPS of $1.53 and Adjusted EPS Excluding Amortization of $1.76 , up 9.3% BURLINGTON, N.C. --(BUSINESS WIRE)--Oct. 18, 2012-- Laboratory Corporation of America ® Holdings (LabCorp ® ) (NYSE: LH) today announced results for the quarter ended September 30, 2012 .

LabCorp Announces Changes to Board of Directors

Thomas P. Mac Mahon to Retire from Board of Directors at the End of His Current Term; Peter M. Neupert Named to the Board of Directors Effective January 1, 2013 BURLINGTON, N.C. --(BUSINESS WIRE)--Oct. 11, 2012-- Laboratory Corporation of America ® Holdings (LabCorp ® ) (NYSE:LH) today announced

Conversion Right Triggered for LabCorp’s Zero Coupon Convertible Subordinated Notes Due 2021

BURLINGTON, N.C. --(BUSINESS WIRE)--Oct. 1, 2012-- Laboratory Corporation of America ® Holdings (LabCorp ® ) (NYSE: LH) announced today that its Zero Coupon Convertible Subordinated Notes due 2021 (Zero Coupon Notes) may be converted as set forth below.

LabCorp's Zero Coupon Convertible Subordinated Notes Due 2021 to Accrue Contingent Interest

BURLINGTON, N.C. --(BUSINESS WIRE)--Sep. 12, 2012-- Laboratory Corporation of America ® Holdings (LabCorp ® ) (NYSE: LH) announced today that for the period of September 12, 2012 to March 11, 2013 , its Zero Coupon Convertible Subordinated Notes due 2021 (Zero Coupon Notes) will, subject to the

LabCorp is Scheduled to Present at the Morgan Stanley Global Healthcare Conference

BURLINGTON, N.C. --(BUSINESS WIRE)--Sep. 4, 2012-- Laboratory Corporation of America ® Holdings (LabCorp ® ) (NYSE: LH) today announced that David P. King , Chairman and Chief Executive Officer, is scheduled to speak at the Morgan Stanley Global Healthcare Conference in New York, NY .

LabCorp Prices $500 Million in 2.20% Senior Notes Due 2017 and $500 Million in 3.75% Senior Notes Due 2022

BURLINGTON, N.C. --(BUSINESS WIRE)--Aug. 20, 2012-- Laboratory Corporation of America ® Holdings (LabCorp ® ) (NYSE: LH) announced today that it has priced its offering of $1 billion in senior notes. The offering consists of two tranches: $500 million aggregate principal amount of 2.20% Senior

LabCorp Announces Proposed Sale of Senior Notes

BURLINGTON, N.C. --(BUSINESS WIRE)--Aug. 20, 2012-- Laboratory Corporation of America ® Holdings (LabCorp ® ) (NYSE: LH) announced today that it plans to offer, subject to market and other conditions, senior notes that are expected to be issued in two tranches with maturities of 5 and 10 years (the